Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials
A constantly evolving landscape for clinical trials and drug development research has created challenges for the sector to not only …
Post
-
-
UK health authorities join forces to champion foreign infectious disease trials
Health divisions within the UK government and British non-profit organisations have banded together to support infectious disease trials in Africa, …
-
EnteroBiotix completes enrolment in Phase IIa MAST trial
EnteroBiotix has announced the completion of enrolment in the Phase IIa MAST trial of EBX-102-02 in patients who are undergoing …
-
Kainova reports positive top line results from Phase I EPRAD trial
Canada-based Kainova Therapeutics has reported positive top line results from the Phase I EPRAD study of DT-9081, an oral EP4 …
-
Vertex to seek approval of IgAN drug after Phase III success
Vertex Pharmaceuticals will head to US regulators after its immunoglobulin A nephropathy (IgAN) drug povetacicept was successful in a Phase …
-
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched …
-
Pfizer’s trispecific heads to Phase III on mid-stage AD success
American pharmaceutical giant Pfizer is planning to take its trispecific antibody, tilrekimig, to Phase III in atopic dermatitis (AD) as …
-
Veru enrols first patient in Phase IIb trial of enobosarm and semaglutide combo
Veru has announced the first patient enrolment in its Phase IIb PLATEAU study assessing the combination of enobosarm, an oral …
-
AbbVie reports topline data from Phase I ABBV-295 trial
AbbVie has reported positive top line data from the multiple ascending dose (MAD) section of its Phase I trial of …
-
Roche’s oral SERD fails in Phase III breast cancer trial
Roche’s oral selective oestrogen receptor degrader (SERD) has failed to meet its primary endpoint in a Phase III breast cancer …
-
Analysts tout market potential of Xenon’s epilepsy drug on Phase III win
Analysts have touted the market potential of Xenon Pharmaceuticals’ novel epilepsy drug, azetukalner, following a positive late-stage readout in patients …
-
Study explores links between gestational diabetes, prenatal depression and childhood obesity
In the US, the burden of childhood obesity has posed a formidable public health problem. Obesity in early life predisposes …
-
Long-term aspirin use is associated with lower ovarian cancer risk
Ovarian cancer is a leading cause of gynaecological cancer mortality worldwide. Early symptoms of ovarian cancer can include decreased appetite, …
-
Opening clinical trials to pregnant women
Pregnant and breastfeeding women have historically been excluded from medical research, resulting in substantial gaps in evidence on the safety …
-
Vinay Prasad to leave the FDA again
Vinay Prasad is once again set to depart from his role at the US Food and Drug Administration (FDA), after …
